A 52-year-old, white female developed low-grade fever, cough, and dyspnea after 8 weeks treatment with sodium aurothiomalate for rheumatoid arthritis.
cough
sodium aurothiomalate
dyspnea
sodium aurothiomalate
low-grade fever
sodium aurothiomalate